Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. (Q51184875)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 September 2007

Language	Label	Description	Also known as
English	Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.	scientific article published on 26 September 2007

Statements

scholarly article

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. (English)

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

20

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

21

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

1 reference

ORCID Public Data File 2021

author name string

Pagano L

1

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

Caira M

2

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

Nosari A

3

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

Van Lint MT

4

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

Candoni A

5

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

Offidani M

6

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

Aloisi T

7

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

Irrera G

8

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

Bonini A

9

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

Picardi M

10

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

Caramatti C

11

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

Invernizzi R

12

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

Mattei D

13

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

Melillo L

14

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

de Waure C

15

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

Reddiconto G

16

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

Fianchi L

17

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

Valentini CG

18

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

Girmenia C

19

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

language of work or name

0 references

publication date

26 September 2007

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

Clinical Infectious Diseases

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

45

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

9

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

1161-1170

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Risk factors and attributable mortality associated with superinfections in neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000.

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Invasive mold infections in allogeneic bone marrow transplant recipients.

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Aspergillosis case-fatality rate: systematic review of the literature

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

The epidemiology of fusariosis in patients with haematological diseases. Gimema Infection Programme

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Increase in aspergillosis and severe mycotic infection in patients with leukemia and MDS: comparison of the data from the Annual of the Pathological Autopsy Cases in Japan in 1989, 1993 and 1997.

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720 patients with haematological malignancy

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Risk of resistance associated with fluconazole prophylaxis: systematic review

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients

1 reference

https://api.crossref.org/works/10.1086%2F522189

21 January 2018

Identifiers

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/17918077

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51184875&oldid=1582656583"